CD40 ligand fusion protein vaccine

Details for Australian Patent Application No. 2006311752 (hide)

Owner Sidney Kimmel Cancer Center

Inventors Deisseroth, Albert; Tang, Yucheng

Agent Spruson & Ferguson

Pub. Number AU-A-2006311752

PCT Pub. Number WO2007/056266

Priority 60/755,885 04.01.06 US; 60/793,206 19.04.06 US; 60/734,136 07.11.05 US; 60/853,184 20.10.06 US; 60/789,270 04.04.06 US

Filing date 6 November 2006

Wipo publication date 18 May 2007

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C07K 1/00 (2006.01) General processes for the preparation of peptides

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056266 Priority application(s): WO2007/056266

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311756-Sampling threshold and gain for satellite navigation receiver

2006311734-Methods of sensitizing cancer to therapy-induced cytotoxicity